2020•Frontiers in MicrobiologyOpen access

Clinical Impact of Antibiotics for the Treatment of Pseudomonas aeruginosa Biofilm Infections

Elodie Olivares, Stéphanie Badel-Berchoux, Christian Provot, Gilles Prévost, Thierry Bernardi, François Jehl

Open full text 189 citations

Abstract

Bacterial biofilms are highly recalcitrant to antibiotic therapies due to multiple tolerance mechanisms. The involvement of Pseudomonas aeruginosa in a wide range of biofilm-related infections often leads to treatment failures. Indeed, few current antimicrobial molecules are still effective on tolerant sessile cells. In contrast, increasingly studies showed that conventional antibiotics can, at low concentrations, induce a phenotype change in bacteria and consequently, the biofilm formation. Understanding the clinical effects of antimicrobials on the biofilm establishment is essential to avoid the use of inappropriate treatments in the case of biofilm infections. This article reviews the current knowledge about the bacterial growth within a biofilm and the preventive or inducer impact of standard antimicrobials on its formation by P. aeruginosa. The effect of antibiotics, used to treat biofilms of others bacterial species as Staphylococcus aureus or Escherichia coli, was also briefly mentioned. Finally, it describes two in vitro devices, which could potentially be used as antibiotic susceptibility testing for adherent bacteria.

Open-access reader

About this research paper

What this paper is about

Bacterial biofilms are highly recalcitrant to antibiotic therapies due to multiple tolerance mechanisms. The involvement of Pseudomonas aeruginosa in a wide range of biofilm-related infections often leads to treatment failures. Indeed, few current antimicrobial molecules are still effective on tolerant sessile cells. In contrast, increasingly studies showed that conventional antibiotics can, at low concentrations, induce a phenotype change in bacteria and consequently, the biofilm formation. Understanding the clinical effects of antimicrobials on the biofilm establishment is essential to avoid the use of inappropriate treatments in the case of biofilm infections. This article reviews the current knowledge about the bacterial growth within a biofilm and the preventive or inducer impact of standard antimicrobials on its formation by P. aeruginosa. The effect of antibiotics, used to treat biofilms of others bacterial species as Staphylococcus aureus or Escherichia coli, was also briefly mentioned. Finally, it describes two in vitro devices, which could potentially be used as antibiotic susceptibility testing for adherent bacteria.

Why it matters

OpenAlex reports 189 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Bacterial biofilms are highly recalcitrant to antibiotic therapies due to multiple tolerance mechanisms. The involvement of Pseudomonas aeruginosa in a wide range of biofilm-related infections often leads to treatment failures. Indeed, few current antimicrobial molecules are still effective on tolerant sessile cells. In contrast, increasingly studies showed that conventional antibiotics can, at low concentrations, induce a phenotype change in bacteria and consequently, the biofilm formation. Understanding the clinical effects of antimicrobials on the biofilm establishment is essential to avoid the use of inappropriate treatments in the case of biofilm infections. This article reviews the current knowledge about the bacterial growth within a biofilm and the preventive or inducer impact of standard antimicrobials on its formation by P. aeruginosa. The effect of antibiotics, used to treat biofilms of others bacterial species as Staphylococcus aureus or Escherichia coli, was also briefly mentioned. Finally, it describes two in vitro devices, which could potentially be used as antibiotic susceptibility testing for adherent bacteria.

Key concepts: Pseudomonas aeruginosa, Biofilm, Antibiotics, Microbiology, Biology, Medicine, Bacteria, Genetics

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Impact of Antibiotics for the Treatment of Pseudomonas aeruginosa Biofilm Infections — Research Paper | ScholarLens